The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Sign in to access this content
Sign InAmwell (NYSE: AMWL) reported a significant improvement in its 2025 financial performance, sharply reducing its net loss to $95.0 million from $212.6 million in 2024. The company also enhanced its 2025 Adjusted EBITDA, improving it to $(39.9) million from $(134.4) million previously. However, Amwell issued cautious revenue guidance for 2026, forecasting figures between $195 million and $205 million. Conversely, the company projects continued improvement in 2026 Adjusted EBITDA, expecting it to reach a range of $(24) million to $(18) million. Amwell aims to achieve positive cash flow from operations by the fourth quarter of 2026, driven by its strategic shift towards a leaner, more efficient model.